Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VRCA
#3539
Verrica Pharmaceuticals Inc. - Common Stock
5.7
6
USD
+9436.42%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9436.42%
Monthly Change
-13.64%
6 month change
-4.32%
Year Change
-4.32%
Previous Close
0.0
6
Open
5.7
6
Low
5.7
6
High
5.7
6
Volume
4
Markets
US Stock Market
Healthcare
VRCA
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
2.54 M
2.75 M
4.19 M
4.24 M
9.18 M
17.18 M
17.18 M
Valuation ratios
Enterprise value
282.14 M
236.32 M
86.26 M
219.32 M
17.92 M
112.61 M
82.56 M
Price to earnings ratio
—
—
-4
-4.6
-0.47
-4.95
-5.46
Price to sales ratio
—
—
10.89
60.26
4.79
2.49
1.69
Price to cash flow ratio
—
—
5.28
8
0.6
-5.02
-6.68
Price to book ratio
—
—
2.46
15.62
3.68
3.58
-10.7
Enterprise value to EBITDA ratio
—
-7.69
-4.12
-3.34
-0.27
-9.23
-5.98
Profitability ratios
Return on assets %
-0.58
-0.44
-0.55
-0.82
-1.41
-0.38
-0.25
Return on equity %
-1.29
-1.08
-0.61
-3.39
7.77
-0.72
-0.6
Return on invested capital %
-259.12
-209.79
-160.72
-2 364.37
-972.74
-305.87
—
Gross margin %
—
100
100
90.24
65.64
98.59
100
Operating margin %
—
-257.57
-235.78
-1 283.35
-871.25
-34.25
-193.41
EBITDA margin %
—
-256.04
-231.91
-1 282.38
-892.92
-34.29
-191.08
Net margin %
—
-292.33
-271.11
-1 307.47
-1 012.15
-50.27
-192.75
Liquidity ratios
Quick ratio
—
—
—
4.49
1.68
2.45
1.98
Current ratio
1.71
1.61
11.31
4.55
1.76
2.59
2.1
Inventory turnover
—
—
—
—
—
0.22
—
Asset turnover
—
0.16
0.14
0.08
0.11
0.75
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.47
0.5
—
0.53
0.57
0
—
Long term debt to total equity ratio
1.06
1.23
—
2.17
-3.14
0
—
Per share metrics
Operating cash flow per share
—
—
-5.46
-8.51
-11.76
-1.65
-0.9
EBIT per share
—
—
-6.23
-14.61
-13.23
-1.19
-0.85
EBITDA per share
—
—
-6.13
-14.49
-13.04
-1.15
-0.81
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
10.03
15.34
1.93
2.83
0.97
Net current asset value per share
—
—
11.45
17.1
9.88
3.99
1.6
Tangible book value per share
—
—
11.72
4.36
-1.9
2.32
0.75
Working capital per share
—
—
10.44
13.34
4.28
2.45
0.84
Book value per share
—
—
11.72
4.36
-1.9
2.32
0.75
News
Verrica Pharmaceuticals Inc. (VRCA) Q1 2026 Earnings Call Transcript
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates
Neurocrine Biosciences (NBIX) Beats Q1 Earnings and Revenue Estimates
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript
Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan
Verrica’s partner launches molluscum treatment in Japan
Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why
New Strong Buy Stocks for February 2nd
How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating
Verrica doses first patient in phase 3 trial for common wart treatment